Bailard, Inc. Zymeworks Inc. Transaction History

Bailard, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 10, 2022	SELL	$15.19 - $29.33 $1.11 Million - $2.15 Million	-73,200 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$27.35 - $37.28 $451,275 - $615,120	-16,500 Reduced 18.39%	73,200 $2.13 Million
Q2 2021 Aug 13, 2021	BUY	$26.5 - $38.23 $694,300 - $1 Million	26,200 Added 41.26%	89,700 $3.11 Million
Q1 2021 May 13, 2021	BUY	$29.83 - $56.81 $1.89 Million - $3.61 Million	63,500 New	63,500 $2.01 Million

296K

Ticker ZYME
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,694,400
Market Cap $816M
Description
Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a novel bispecific antibody that is in Phase 1 and Phase 2 clinical trials for the treatment of biliary tract, gastroesophageal adenocarcinomas...

Get notified when there are updates to the investment portfolio of Bailard, Inc., based on Form 13F filings with the SEC.

Stay updated on Bailard, Inc. with notifications on news.